Foghorn Therapeutics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $72.4M | $213.6M |
| Jun 2022 | — | $47.6M | $61.2M |
| Sep 2022 | — | $24.3M | $87.6M |
| Dec 2022 | — | $112.0K | $52.2M |
| Mar 2023 | — | $-24.6M | $50.6M |
| Jun 2023 | — | $-49.4M | $57.7M |
| Sep 2023 | — | $-57.4M | $70.3M |
| Dec 2023 | — | $-77.2M | $80.3M |
| Mar 2024 | — | $-97.5M | $79.3M |
| Jun 2024 | — | $-14.3M | $138.9M |
| Sep 2024 | — | $-28.3M | $57.7M |
| Dec 2024 | — | $-45.5M | $55.5M |
| Mar 2025 | — | $-61.7M | $61.0M |
| Jun 2025 | — | $-76.7M | $72.6M |
| Sep 2025 | — | $-89.7M | $89.3M |
| Dec 2025 | — | $-108.5M | $80.9M |
| Mar 2026 | — | $-76.4M | $87.7M |
| Jun 2026 | — | $-81.0M | $68.1M |